Drug Interactions in Dental Practice

Elkin N. Yaşlılarda Polifarmasi ve Akılcı İlaç Kullanımına Aile Hekimliği Yaklaşımı. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi. 2020(11):279-90.

Mohan S, Govila V, Saini A, Verma SC. Prime drug interplay in dental practice. Journal of Clinical and Diagnostic Research: JCDR. 2016;10(3):ZE07.

Vrbanac J, Slauter R. ADME in drug discovery. A comprehensive guide to toxicology in nonclinical drug development: Elsevier; 2017. p. 39-67.

Deng J, Zhu X, Chen Z, Fan CH, Kwan HS, Wong CH, et al. A review of food–drug interactions on oral drug absorption. Drugs. 2017;77(17):1833-55.

Vuignier K, Schappler J, Veuthey J-L, Carrupt P-A, Martel S. Drug–protein binding: a critical review of analytical tools. Analytical and bioanalytical chemistry. 2010;398(1):53-66.

Niu J, Straubinger RM, Mager DE. Pharmacodynamic drug–drug interactions. Clinical Pharmacology & Therapeutics. 2019;105(6):1395-406.

Christensen H, Baker M, Tucker GT, Rostami-Hodjegan A. Prediction of plasma protein binding displacement and its implications for quantitative assessment of metabolic drug–drug interactions from in vitro data. Journal of pharmaceutical sciences. 2006;95(12):2778-87.

Lee J, Beers JL, Geffert RM, Jackson KD. A review of CYP-mediated drug interactions: mechanisms and in vitro drug-drug interaction assessment. Biomolecules. 2024;14(1):99.

Hersh EV, Moore PA. Adverse drug interactions in dentistry. Periodontology 2000. 2008;46(1):109-42.

Hersh EV, Moore PA. Drug interactions in dentistry: the importance of knowing your CYPs. The Journal of the American Dental Association. 2004;135(3):298-311.

Pichai E, Lakshmanan M. Drug elimination. Introduction to basics of pharmacology and toxicology: Volume 1: General and molecular pharmacology: Principles of drug action: Springer; 2019. p. 117-29.

Garza AZ, Park SB, Kocz R. Drug elimination. 2019.

Sun L, Mi K, Hou Y, Hui T, Zhang L, Tao Y, et al. Pharmacokinetic and pharmacodynamic drug–drug interactions: research methods and applications. Metabolites. 2023;13(8):897.

Algera MH, Kamp J, van der Schrier R, van Velzen M, Niesters M, Aarts L, et al. Opioid-induced respiratory depression in humans: a review of pharmacokinetic–pharmacodynamic modelling of reversal. British Journal of Anaesthesia. 2019;122(6):e168-e79.

Haghbin H, Zakirkhodjaev N, Husain FF, Lee-Smith W, Aziz M. Risk of gastrointestinal bleeding with concurrent use of NSAID and SSRI: a systematic review and network meta-analysis. Digestive Diseases and Sciences. 2023;68(5):1975-82.

Theriot J, Sabir S, Azadfard M. Opioid Antagonists. StatPearls. Treasure Island (FL). StatPearls Publishing Copyright; 2025.

Fournier J-P, Sommet A, Bourrel R, Oustric S, Pathak A, Lapeyre-Mestre M, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study. European journal of clinical pharmacology. 2012;68(11):1533-40.

Saraga MA, Fotopoulos I, Zisis V, Poulopoulos A, Dabarakis N, Lillis T. Pharmacological Interactions of Epinephrine at Concentrations Used in Dental Anesthesiology: An Updated Narrative Review. Reports. 2025;8(4):224.

Poornachitra P, Narayan V, Maragathavalli G. An Update on Common Drug Interactions in Dental Practice. Journal of Indian Academy of Oral Medicine and Radiology. 2023;35(2):284-5.

Shionoya Y, Nakamura E, Tsujimoto G, Koyata T, Yasuda A, Nakamura K, et al. Hemodynamic impact of drug interactions with epinephrine and antipsychotics under general anesthesia with propofol. Anesthesia Progress. 2021;68(3):141-5.

Hersh EV, Giannakopoulos H. Beta-adrenergic blocking agents and dental vasoconstrictors. Dental Clinics. 2010;54(4):687-96.

Becker DE. Psychotropic drugs: implications for dental practice. Anesthesia progress. 2008;55(3):89-99.

Hersh EV, Moore PA. Three serious drug interactions that every dentist should know about. Compendium. 2015;36(6):739-44.

Meechan JG. Plasma potassium changes in hypertensive patients undergoing oral surgery with local anesthetics containing epinephrine. Anesthesia Progress. 1997;44(3):106.

Deol N, Alvarez G, Elrabi O, Chen G, Ferraro N. A comparative review of epinephrine and phenylephrine as vasoconstrictors in dental anesthesia: exploring the factors behind epinephrine's prevalence in the US. Journal of Dental Anesthesia and Pain Medicine. 2023;23(6):293.

Seminario-Amez M, González-Navarro B, Ayuso-Montero R, Jané-Salas E, López-López J. Use of local anesthetics with a vasoconstrictor agent during dental treatment in hypertensive and coronary disease patients. A systematic review. Journal of Evidence Based Dental Practice. 2021;21(2):101569.

Figallo MAS, Cayón RTV, Lagares DT, Flores JRC, Portillo GM. Use of anesthetics associated to vasoconstrictors for dentistry in patients with cardiopathies. Review of the literature published in the last decade. Journal of Clinical and Experimental Dentistry. 2012;4(2):e107.

Niwa H, Sugimura M, Satoh Y, Tanimoto A. Cardiovascular response to epinephrine-containing local anesthesia in patients with cardiovascular disease. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2001;92(6):610-6.

Rowe S, Patel N, Dave M. The clinical implications of cocaine use in dentistry. British Dental Journal Team. 2025;12(5):237-8.

Whyte K, Whitesmith R, Reid J. The effect of diuretic therapy on adrenaline-induced hypokalaemia and hypomagnesaemia. European journal of clinical pharmacology. 1988;34(4):333-7.

Edinoff AN, Swinford CR, Odisho AS, Burroughs CR, Stark CW, Raslan WA, et al. Clinically relevant drug interactions with monoamine oxidase inhibitors. Health psychology research. 2022;10(4):39576.

Saraghi M, Golden LR, Hersh EV. Anesthetic considerations for patients on antidepressant therapy—part I. Anesthesia progress. 2017;64(4):253-61.

Harbell MW, Dumitrascu C, Bettini L, Yu S, Thiele CM, Koyyalamudi V. Anesthetic considerations for patients on psychotropic drug therapies. Neurology International. 2021;13(4):640-58.

Moraczewski J, Awosika AO, Aedma KK. Tricyclic antidepressants. StatPearls [Internet]: StatPearls Publishing; 2023.

Dunbar D, Ouanounou A. An update on drug interactions involving anti-inflammatory and analgesic medications in oral and maxillofacial medicine: a narrative review. Frontiers of Oral and Maxillofacial Medicine. 2025;7.

Mendell J, Lee F, Chen S, Worland V, Shi M, Samama MM. The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitor. Journal of cardiovascular pharmacology. 2013;62(2):212-21.

Bakhriansyah M, Souverein PC, de Boer A, Klungel OH. Gastrointestinal toxicity among patients taking selective COX‐2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case–control study. pharmacoepidemiology and drug safety. 2017;26(10):1141-8.

Vazquez SR. Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions. Blood, The Journal of the American Society of Hematology. 2018;132(21):2230-9.

Kim G-H. Renal effects of prostaglandins and cyclooxygenase-2 inhibitors. Electrolytes & Blood Pressure: E & BP. 2008;6(1):35-41.

Prieto-García L, Pericacho M, Sancho-Martínez SM, Sánchez Á, Martínez-Salgado C, López-Novoa JM, et al. Mechanisms of triple whammy acute kidney injury. Pharmacology & therapeutics. 2016;167:132-45.

Nunes RP. Lithium interactions with non-steroidal anti-inflammatory drugs and diuretics–A review. Archives of Clinical Psychiatry (São Paulo). 2018;45:38-40.

Malhi GS, Bell E, Outhred T, Berk M. Lithium therapy and its interactions. Australian prescriber. 2020;43(3):91.

Murphy N, Redahan L, Lally J. Management of lithium intoxication. British Journal of Psychiatry Advances. 2023;29(2):82-91.

Svanström H, Lund M, Melbye M, Pasternak B. Concomitant use of low‐dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis. Pharmacoepidemiology and drug safety. 2018;27(8):885-93.

Maeda A, Tsuruoka S, Kanai Y, Endou H, Saito K, Miyamoto E, et al. Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells. European journal of pharmacology. 2008;596(1-3):166-72.

MacLeod-Glover N, Mink M, Yarema M, Chuang R. Digoxin toxicity: Case for retiring its use in elderly patients? Canadian Family Physician. 2016;62(3):223-8.

Anglin R, Yuan Y, Moayyedi P, Tse F, Armstrong D, Leontiadis GI. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Official journal of the American College of Gastroenterology| ACG. 2014;109(6):811-9.

Bahuva R, Yee J, Gupta S, Atreja A. SSRI and the risk of gastrointestinal bleed: more than what meets the eye. Official journal of the American College of Gastroenterology| ACG. 2015;110(2):346.

Blough ER, Wu M. Acetaminophen: beyond pain and fever-relieving. Frontiers in pharmacology. 2011;2:72.

Ndetan H, Evans Jr MW, Singal AK, Brunner LJ, Calhoun K, Singh KP. Light to moderate drinking and therapeutic doses of acetaminophen: An assessment of risks for renal dysfunction. Preventive medicine reports. 2018;12:253-8.

Caldeira D, Costa J, Barra M, Pinto FJ, Ferreira JJ. How safe is acetaminophen use in patients treated with vitamin K antagonists? A systematic review and meta-analysis. Thrombosis Research. 2015;135(1):58-61.

Kim S-J, Seo JT. Selection of analgesics for the management of acute and postoperative dental pain: a mini-review. Journal of Periodontal & Implant Science. 2020;50(2):68.

Kotlinska-Lemieszek A, Klepstad P, Haugen DF. Clinically significant drug–drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review. Drug design, development and therapy. 2015:5255-67.

Baldo BA, Rose MA. The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review. British journal of anaesthesia. 2020;124(1):44-62.

Witkiewitz K, Vowles KE. Alcohol and opioid use, co‐use, and chronic pain in the context of the opioid epidemic: A critical review. Alcoholism: clinical and experimental research. 2018;42(3):478-88.

Hassamal S, Miotto K, Dale W, Danovitch I. Tramadol: understanding the risk of serotonin syndrome and seizures. The American journal of medicine. 2018;131(11):1382. e1-. e6.

Teal L, Sheller B, Susarla HK. Pediatric Odontogenic Infections. Oral and Maxillofacial Surgery Clinics. 2024;36(3):391-9.

Cirkel LL, Herrmann JM, Ringel C, Wöstmann B, Kostev K. Antibiotic prescription in dentistry: Trends, patient demographics, and drug preferences in Germany. Antibiotics. 2025;14(7):676.

Jafari F, Arasteh O, Hosseinjani H, Allahyari A, Ataei Azimi S, Askari VR. A critical review of methotrexate clinical interactions: role of transporters. Expert Opinion on Drug Metabolism & Toxicology. 2023;19(2):91-107.

Huang X, He F, Deng Y, Shi S. Severe hematologic toxicity after low-dose methotrexate in ectopic pregnancy: role of MTHFR polymorphism and drug interaction-a case report and literature review. Frontiers in Pharmacology. 2025;16:1671369.

Hall JJ, Bolina M, Chatterley T, Jamali F. Interaction between low-dose methotrexate and nonsteroidal anti-inflammatory drugs, penicillins, and proton pump inhibitors: a narrative review of the literature. Annals of Pharmacotherapy. 2017;51(2):163-78.

Sathi N, Dawson J. Methotrexate-induced pancytopenia associated with co-prescription of penicillin and trimethoprim. Clinical rheumatology. 2007;26(1):134-5.

Vega AJ, Smith C, Matejowsky HG, Thornhill KJ, Borne GE, Mosieri CN, et al. Warfarin and antibiotics: drug interactions and clinical considerations. Life. 2023;13(8):1661.

Davydov L, Yermolnik M, Cuni LJ. Warfarin and amoxicillin/clavulanate drug interaction. Annals of Pharmacotherapy. 2003;37(3):367-70.

Elkhoury D, Reddy N, Venkatraman D, Patel P, Montalbano M. Exploring Antibiotic-Mediated Disruption of Enterohepatic Circulation and Combined Oral Contraceptive Efficacy: A Systematic Review. Women's Health Reports. 2025;6(1):599-604.

Curtis KM. US medical eligibility criteria for contraceptive use, 2016. MMWR Recommendations and Reports. 2016;65.

Simmons KB, Haddad LB, Nanda K, Curtis KM. Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review. American journal of obstetrics and gynecology. 2018;218(1):88-97. e14.

Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic acids research. 2018;46(D1):D1074-D82.

Boddepalli R, Keerthana B, Vidyasagar B, Pasala A. Drug alcohol interactions-a review. Asian Journal of Hospital Pharmacy. 2022:62-4.

Tao RE, Prajapati S, Pixley JN, Grada A, Feldman SR. Oral tetracycline-class drugs in dermatology: Impact of food intake on absorption and efficacy. Antibiotics. 2023;12(7):1152.

Rodríguez AT, i Barceló AF, González MB, Esnal DE, Muner DS, Martínez JA, et al. Clinically important pharmacokinetic drug-drug interactions with antibacterial agents. Revista Española de Quimioterapia. 2024;37(4):299.

Li DQ, Kim R, McArthur E, Fleet JL, Bailey DG, Juurlink D, et al. Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4. Cmaj. 2015;187(3):174-80.

Sparkes T, Lemonovich TL, Practice AIDCo. Interactions between anti‐infective agents and immunosuppressants—guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clinical transplantation. 2019;33(9):e13510.